This inventor holds 6 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Blasticon Biotechnologische Forschung Gmbh, Trizell Limited. Active years: 2006-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006-2025
Title: Fred Fändrich: Innovator in Immunoregulatory Macrophage Research
Introduction
Fred Fändrich is a notable inventor based in Kiel, Germany. He has made significant contributions to the field of biotechnology, particularly in the area of immunoregulatory macrophages. With a total of six patents to his name, Fändrich's work focuses on innovative treatments for diseases associated with blood vessel abnormalities.
Latest Patents
Fändrich's latest patents include groundbreaking research on the use of immunoregulatory macrophages for treating angiopathies. His inventions specifically address the treatment of micro- and macroangiopathies of the lower limbs. Additionally, his work promotes tissue remodeling to facilitate wound healing. The pharmaceutical compositions he has developed for these treatments incorporate immunoregulatory macrophages, showcasing his commitment to advancing medical science.
Career Highlights
Throughout his career, Fred Fändrich has worked with various companies, including Blasticon Biotechnologische Forschung GmbH and Trizell Limited. His experience in these organizations has allowed him to refine his research and contribute to significant advancements in biotechnology.
Collaborations
Fändrich has collaborated with notable professionals in his field, including Bernd Karl Friedrich Kremer and Maren Née Schulze Ruhnke. These partnerships have further enriched his research and innovation efforts.
Conclusion
Fred Fändrich stands out as a prominent inventor in the realm of immunoregulatory macrophage research. His contributions have the potential to transform treatments for vascular diseases and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
